This growth is reflective of the fast-growing adoption of AYUSH products and services by the public following the outbreak of the COVID-19 pandemic. At present, IMPCL is manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for various diseases spectrum.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2QnQc6G
via IFTTT
0 comments:
Post a Comment